The avidity of tumor‐specific T cells amplified by a plasmacytoid dendritic cell‐based assay can predict the clinical evolution of melanoma patients

Publisher: John Wiley & Sons Inc

E-ISSN: 1755-148x|31|1|82-94

ISSN: 1755-1471

Source: PIGMENT CELL & MELANOMA RESEARCH, Vol.31, Iss.1, 2018-01, pp. : 82-94

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract